描述

A biomarker is a biological characteristic that is objectively measured and evaluated as an indicator of normal biological or pathological processes, or a response to a therapeutic intervention. Examples include patterns of gene expression, levels of a particular protein in body fluids, or changes in electrical activity in the brain. The global biomarkers market is poised to grow by US$ 48.0 亿期间 2022-2028, 复合年增长率为 12.3% 在预测期内, 据数据和分析公司 StrategyHelix 称.

该报告提供了该时期的最新市场规模数据 2018-2021 并预测到 2028 covering key market aspects like sales value for biomarkers. The global biomarkers market is segmented on the basis of product, 技术, 疾病, 最终用户, 和地区. 副产品, the global biomarkers market has been segmented into consumables, instruments, 服务, 软件. 在 2021, the consumables segment made up the largest share of revenue generated by the biomarkers market. 以技术为基础, the global biomarkers market is categorized into genomics, proteomics, metabolomics, imaging, 其他的. The proteomics segment was the largest contributor to the global biomarkers market in 2021. On the basis of disease, the global biomarkers market has been segmented into cancer, cardiovascular and metabolic diseases, neurodegenerative diseases, infectious diseases, autoimmune diseases, 其他的. The cancer segment is estimated to account for the largest share of the global biomarkers market. 按最终用户, the global biomarkers market has been segmented into biopharmaceutical and biotech companies, CROs, hospitals and diagnostics, research and academic institutes. The hospitals and diagnostics segment held the largest share of the global biomarkers market in 2021 预计在预测期内将持有其份额. 地理上, the global biomarkers market is segmented into Emerging Region, 欧洲, 北美.

The global biomarkers market is highly competitive. The prominent players operating in the global biomarkers market include Abbott Laboratories, Agilent Technologies Inc., 拜耳公司, Becton Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corp., Bruker Corp., Canon Medical Systems Corporation, Danaher Corporation, F. Hoffmann-La Roche Ltd, FUJIFILM VisualSonics Inc., GE Healthcare, Illumina Inc., JEOL Ltd., 皇家飞利浦公司, Oxford Nanopore Technologies Limited, PerkinElmer Inc., QIAGEN N.V., Shimadzu Corporation, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Waters Corporation.

该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the biomarkers market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.

报告范围

产品: consumables, instruments, 服务, 软件
技术: genomics, proteomics, metabolomics, imaging, 其他的
疾病: cancer, cardiovascular and metabolic diseases, neurodegenerative diseases, infectious diseases, autoimmune diseases, 其他的
最终用户: biopharmaceutical and biotech companies, CROs, hospitals and diagnostics, research and academic institutes
地区: Emerging Region, 欧洲, 北美
考虑的年数: 本报告涵盖期间 2018 到 2028

利益相关者的主要好处

– Get a comprehensive picture of the global biomarkers market
– 精准定位增长领域和投资趋势

目录

部分 1. 介绍
– 研究范围
– 学习时段
– 地理范围
– 研究方法论
部分 2. Biomarkers market overview
部分 3. 按产品划分的市场细分
– Consumables
– 仪器
– 服务
– 软件
部分 4. 按技术划分的市场细分
– Genomics
– Proteomics
– Metabolomics
– Imaging
– 其他的
部分 5. Market breakdown by disease
– Cancer
– Cardiovascular and metabolic diseases
– Neurodegenerative diseases
– Infectious diseases
– Autoimmune diseases
– 其他的
部分 6. 按最终用户划分的市场细分
– Biopharmaceutical and biotech companies
– CROs
– Hospitals and diagnostics
– Research and academic institutes
部分 7. 按地区划分的市场细分
– Emerging Region
– 欧洲
– 北美
部分 8. 重点企业
– 雅培实验室
– Agilent Technologies Inc.
– 拜耳公司
– Becton, Dickinson and Company
– Bio-Rad Laboratories, 公司.
– Bio-Techne Corp.
– Bruker Corp.
– Canon Medical Systems Corporation
– Danaher Corporation
– F. Hoffmann-La Roche Ltd
– FUJIFILM VisualSonics Inc.
– GE Healthcare
– Illumina, 公司.
– JEOL Ltd.
– 皇家飞利浦公司.
– Oxford Nanopore Technologies Limited
– PerkinElmer, 公司.
– QIAGEN N.V.
– Shimadzu Corporation
– Siemens Healthineers AG
– Thermo Fisher Scientific Inc.
– Waters Corporation
关于StrategyHelix
免责声明